Atlas Trials

Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)

Clinical trial NCT00550862 · TERMINATED

Trial details

NCT number
NCT00550862
Sponsor
Intercept Pharmaceuticals
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Liver Cirrhosis, Biliary
Start date
2007-10-01
Primary completion
2009-08-01
Enrollment
165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.